Scientists sit poised at a singular moment in the history of vaccine research. Genomics and systems biology have fuelled advances in our understanding of human…
ADITEC’s Scientific and Socio-Economic Impact Report Thomson Reuters Impact Report Published The ADITEC Scientific and Socio-Economic Impact Report by Thomson Reuters, first presented at the…
The European Parliament holds an event on “Vaccine Research and Development in Europe” highlighting the ADITEC success story The Science and Technology Options Assessment (STOA)…
A shot in the arm for vaccine research Published by the European Commission and features on their website The European Commission highlights the ADITEC project as…
Call for EC Funded Commissioned Research for SMEs and Public Health Organizations Support for Vaccine Development Deadline: Friday 6 May 2016 5:00 p.m. CET Commissioned…
Support for Vaccine Development Deadline: Friday 6 May 2016 5:00 p.m. CET The High Impact project on Advanced Immunization Technologies (ADITEC), funded through the 7th…
Support for Vaccine Development Deadline: 30 October 2015 5:00 p.m. CET Anticipated Decision Date 30 November 2015 The High Impact project on Advanced Immunization Technologies…
Adjuvanted trivalent influenza vaccine study in infants: A randomised controlled trial to determine the kinetics of the functional genomic response In the 2012 influenza season, ADITEC…
Happy New Year! The ADITEC project team wishes all partners, collaborators and those who are interested in our work, a very Happy New year! In…
Support for Vaccine Development Deadline: 30 Jan 2015 5:00 p.m. CET Anticipated Decision Date 8 April 2015 The High Impact project on Advanced Immunization Technologies…
You must be logged in to post a comment.